|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155.80 CHF | +1.83% |
|
-0.64% | -0.38% |
| Mar. 13 | Medacta Group SA, 2025 Earnings Call, Mar 13, 2026 | |
| Mar. 13 | Medacta Group Reports Higher FY25 Attributable Profit, Revenue | MT |
Business description: Medacta Group SA
Number of employees: 2,041
Sales by Activity: Medacta Group SA
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
Medical Products | 302M | 363M | 437M | 511M | 591M |
Geographical breakdown of sales: Medacta Group SA
| Fiscal Period: December | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|
EMEA | - | - | - | 242M | 284M |
North America | - | - | - | 154M | 179M |
Asia Pacific | - | - | - | 104M | 115M |
LATAM | - | - | - | 10.16M | 12.45M |
Australia | 41.24M | 50.64M | 54M | - | - |
United States | 92.23M | 108M | 136M | - | - |
Switzerland | 36.11M | 38.17M | 44.8M | - | - |
Europe (Excl. Switzerland) | 93.16M | 118M | 143M | - | - |
North America (Excl. United States) | 495K | 773K | 684K | - | - |
Asia Pacific (Excl. Australia) | 30.76M | 34.28M | 40.36M | - | - |
Row | 8.51M | 12.58M | 18.63M | - | - |
Executive Committee: Medacta Group SA
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 2018-10-31 | |
Corrado Farsetta
DFI | Director of Finance/CFO | 58 | 2010-12-31 |
Anja Pomrehn
IRC | Investor Relations Contact | - | 2024-11-20 |
| Corporate Officer/Principal | - | 2021-01-31 |
Composition of the Board of Directors: Medacta Group SA
| Director | Title | Age | Since |
|---|---|---|---|
Alberto Siccardi
CHM | Chairman | 82 | 1998-12-31 |
| Director/Board Member | 51 | 2017-12-31 | |
| Director/Board Member | 69 | 2018-12-31 | |
Philippe Weber
BRD | Director/Board Member | 61 | 2018-12-31 |
Riccardo Braglia
BRD | Director/Board Member | 66 | 2020-12-17 |
Company details: Medacta Group SA
Group companies: Medacta Group SA
| Name | Category and Sector |
|---|---|
Medacta International SA
 Medacta International SA Medical SpecialtiesHealth Technology Manufactures and sells orthopedic products |
Medical Specialties
|
Other Medical Equipment, Supplies & Distribution
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.83% | -0.64% | +23.85% | +47.26% | 3.93B | |
| -0.10% | -1.40% | -14.74% | +9.62% | 188B | |
| -0.27% | -4.14% | -6.37% | +11.92% | 112B | |
| -0.77% | -2.37% | +35.60% | +134.41% | 68.08B | |
| +0.22% | -2.61% | +59.71% | +104.46% | 58.59B | |
| -0.17% | -4.64% | -29.48% | -31.57% | 45.38B | |
| +0.95% | -5.41% | - | - | 33.65B | |
| -1.56% | -5.67% | -9.12% | -43.23% | 24.72B | |
| +1.05% | -6.92% | -5.32% | +20.18% | 21.04B | |
| +1.32% | +0.51% | -24.86% | +15.66% | 19.15B | |
| Average | +0.25% | -3.33% | +3.25% | +29.86% | 57.41B | |
| Weighted average by Cap. | -0.08% | -2.98% | +0.71% | +31.12% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MOVE Stock
- Company Medacta Group SA
Select your edition
All financial news and data tailored to specific country editions
